🇺🇸 FDA
Pipeline program

YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.

Phase 2 small_molecule active

Quick answer

YERVOY 5 mg/ml concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion. for castration-resistant prostate cancer is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
castration-resistant prostate cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials